PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 61 filers reported holding PRELUDE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $209,156 | +95.4% | 67,688 | +184.5% | 0.00% | – |
| Q2 2023 | $107,046 | -62.1% | 23,788 | -51.9% | 0.00% | – |
| Q1 2023 | $282,127 | +196.3% | 49,496 | +214.0% | 0.00% | – |
| Q4 2022 | $95,215 | -33.9% | 15,764 | -27.5% | 0.00% | – |
| Q3 2022 | $144,000 | -37.9% | 21,735 | -50.9% | 0.00% | – |
| Q2 2022 | $232,000 | +39.8% | 44,295 | +83.9% | 0.00% | – |
| Q1 2022 | $166,000 | -88.2% | 24,090 | -78.7% | 0.00% | – |
| Q4 2021 | $1,411,000 | +420.7% | 113,335 | +1208.9% | 0.00% | – |
| Q3 2021 | $271,000 | -49.2% | 8,659 | -53.5% | 0.00% | – |
| Q2 2021 | $533,000 | -71.7% | 18,617 | -57.2% | 0.00% | – |
| Q1 2021 | $1,885,000 | -24.8% | 43,509 | -47.7% | 0.00% | -100.0% |
| Q3 2020 | $2,507,000 | – | 83,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $69,274,000 | 1.12% |
| Baker Brothers Advisors | 10,123,824 | $69,854,000 | 0.40% |
| HHLR ADVISORS, LTD. | 583,333 | $4,025,000 | 0.08% |
| Rock Springs Capital Management LP | 368,959 | $2,546,000 | 0.06% |
| PDT Partners, LLC | 71,822 | $496,000 | 0.04% |
| Virtus ETF Advisers LLC | 13,048 | $90,000 | 0.04% |
| Corton Capital Inc. | 10,918 | $75,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 23,201 | $160,000 | 0.02% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 24,238 | $167,000 | 0.01% |
| IndexIQ Advisors LLC | 56,750 | $392,000 | 0.01% |